Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17206 | 548 | 34.6 | 75% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SURAMIN | Author keyword | 60 | 28% | 33% | 182 |
| 2 | HT 29 D4 CELLS | Author keyword | 3 | 100% | 1% | 3 |
| 3 | SURAMIN ANALOGUES | Author keyword | 2 | 43% | 1% | 3 |
| 4 | SURAMIN ANALOGS | Author keyword | 1 | 100% | 0% | 2 |
| 5 | ADRENAL CORTICAL INSUFFICIENCY | Author keyword | 1 | 50% | 0% | 1 |
| 6 | AERODYNAM DIRECTORATE | Address | 1 | 50% | 0% | 1 |
| 7 | CHEMOTHERAPY IN PROSTATE CANCER | Author keyword | 1 | 50% | 0% | 1 |
| 8 | CLIN PHARMACOKINET CLIN PHARM | Address | 1 | 50% | 0% | 1 |
| 9 | CLIN PHARMACOKINET PHARMACOMETR | Address | 1 | 50% | 0% | 1 |
| 10 | DEXTRAN SULFATES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SURAMIN | 60 | 28% | 33% | 182 | Search SURAMIN | Search SURAMIN |
| 2 | HT 29 D4 CELLS | 3 | 100% | 1% | 3 | Search HT+29+D4+CELLS | Search HT+29+D4+CELLS |
| 3 | SURAMIN ANALOGUES | 2 | 43% | 1% | 3 | Search SURAMIN+ANALOGUES | Search SURAMIN+ANALOGUES |
| 4 | SURAMIN ANALOGS | 1 | 100% | 0% | 2 | Search SURAMIN+ANALOGS | Search SURAMIN+ANALOGS |
| 5 | ADRENAL CORTICAL INSUFFICIENCY | 1 | 50% | 0% | 1 | Search ADRENAL+CORTICAL+INSUFFICIENCY | Search ADRENAL+CORTICAL+INSUFFICIENCY |
| 6 | CHEMOTHERAPY IN PROSTATE CANCER | 1 | 50% | 0% | 1 | Search CHEMOTHERAPY+IN+PROSTATE+CANCER | Search CHEMOTHERAPY+IN+PROSTATE+CANCER |
| 7 | DEXTRAN SULFATES | 1 | 50% | 0% | 1 | Search DEXTRAN+SULFATES | Search DEXTRAN+SULFATES |
| 8 | DISTAMYCIN A DERIVATIVES | 1 | 50% | 0% | 1 | Search DISTAMYCIN+A+DERIVATIVES | Search DISTAMYCIN+A+DERIVATIVES |
| 9 | DOG DISEASE | 1 | 50% | 0% | 1 | Search DOG+DISEASE | Search DOG+DISEASE |
| 10 | DOXORUBICIN RESISTANT SUBLINES | 1 | 50% | 0% | 1 | Search DOXORUBICIN+RESISTANT+SUBLINES | Search DOXORUBICIN+RESISTANT+SUBLINES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ENHANCE ACTIVITY | 30 | 100% | 2% | 12 |
| 2 | FACTOR RECEPTOR BINDING | 23 | 62% | 4% | 24 |
| 3 | CYTOTOXICITY INVITRO | 17 | 100% | 1% | 8 |
| 4 | HTLV III LAV INFECTION | 13 | 51% | 3% | 18 |
| 5 | CLONE HT29 D4 | 13 | 69% | 2% | 11 |
| 6 | LOW DOSE SURAMIN | 8 | 75% | 1% | 6 |
| 7 | CELL CLONE HT29 D4 | 3 | 100% | 1% | 3 |
| 8 | HT29 D4 CELLS | 2 | 67% | 0% | 2 |
| 9 | AUTOCRINE TRANSFORMATION | 2 | 23% | 1% | 7 |
| 10 | DISTAMYCIN A DERIVATIVES | 2 | 43% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| SURAMIN - A NOVEL ANTINEOPLASTIC AGENT WITH MULTIPLE POTENTIAL MECHANISMS OF ACTION | 1993 | 214 | 108 | 67% |
| Suramin: Clinical Uses and Structure-Activity Relationships | 2008 | 42 | 103 | 63% |
| RECENT RESEARCH ON THE BIOLOGICAL-ACTIVITY OF SURAMIN | 1993 | 211 | 150 | 46% |
| SURAMIN | 1994 | 42 | 22 | 73% |
| Suramin: A molecule with a broad spectrum of biological and therapeutic properties | 1997 | 16 | 37 | 86% |
| SURAMIN - PROTOTYPE OF A NEW GENERATION OF ANTITUMOR COMPOUNDS | 1990 | 136 | 39 | 67% |
| Anti-angiogenic drugs: from bench to clinical trials | 2006 | 71 | 303 | 6% |
| INHIBITION OF CELL SIGNALING PATHWAYS | 1995 | 23 | 123 | 14% |
| DIFFERENTIATION IN HUMAN COLON-TUMOR CELLS - IMPORTANCE OF AUTOCRINE GROWTH-FACTORS | 1992 | 5 | 29 | 34% |
| Cancer biology and hormesis: Comments on Calabrese (2005) | 2005 | 2 | 19 | 16% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AERODYNAM DIRECTORATE | 1 | 50% | 0.2% | 1 |
| 2 | CLIN PHARMACOKINET CLIN PHARM | 1 | 50% | 0.2% | 1 |
| 3 | CLIN PHARMACOKINET PHARMACOMETR | 1 | 50% | 0.2% | 1 |
| 4 | PATHOL MED SL79 | 1 | 50% | 0.2% | 1 |
| 5 | BIOMIDE S | 0 | 33% | 0.2% | 1 |
| 6 | SERV VET OURCES BRANCH | 0 | 33% | 0.2% | 1 |
| 7 | ANGELINI RIC | 0 | 25% | 0.2% | 1 |
| 8 | ONCOL ANAT PATHOL | 0 | 25% | 0.2% | 1 |
| 9 | UTRECHT DEV BIOL | 0 | 25% | 0.2% | 1 |
| 10 | 320 | 0 | 20% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000096144 | CELLULAR INHIBITION//INFECT DIS INVEST SCI//PENTOSAN POLYSULPHATE SODIUM |
| 2 | 0.0000069980 | LAW INTERDISCIPLINE//1 1 DIMETHYL 4 PHENYLPIPERAZINIUM IODIDE//PLATELET PLUG |
| 3 | 0.0000067376 | TNP 470//METHIONINE AMINOPEPTIDASE//AGM 1470 |
| 4 | 0.0000059743 | FIBROBLAST GROWTH FACTOR//FGF RECEPTOR//UNCONVENTIONAL PROTEIN SECRETION |
| 5 | 0.0000057864 | ABIRATERONE//ENZALUTAMIDE//CASTRATION RESISTANT PROSTATE CANCER |
| 6 | 0.0000051292 | FUNCTION INDICES//FADOGIA AGRESTIS//BOUGAINVILLEA SPECTABILIS |
| 7 | 0.0000049632 | CARBOXYAMIDOTRIAZOLE//CARBOXYAMIDO TRIAZOLE//PROOFREADING STIMULATION |
| 8 | 0.0000044207 | PLATELET DERIVED GROWTH FACTOR//PDGF//PDGF RECEPTOR |
| 9 | 0.0000044017 | HEAT SHOCK PROTECTION//ADP RIBOSEPOLYMERASE//CHICKEN EMBRYO CELLS |
| 10 | 0.0000043141 | HEPARANASE//CANC VASC BIOL//PI 88 |